[HTML][HTML] Estimating the global burden of Epstein–Barr virus-related cancers
Background More than 90% of the adult population globally is chronically infected by the
Epstein–Barr virus (EBV). It is well established that EBV is associated with a number of …
Epstein–Barr virus (EBV). It is well established that EBV is associated with a number of …
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
E Campo, SH Swerdlow, NL Harris… - Blood, The Journal …, 2011 - ashpublications.org
Abstract The World Health Organization classification of lymphoid neoplasms updated in
2008 represents a worldwide consensus on the diagnosis of these tumors and is based on …
2008 represents a worldwide consensus on the diagnosis of these tumors and is based on …
[HTML][HTML] Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma
X Li, Y Cheng, M Zhang, J Yan, L Li, X Fu… - Journal of hematology & …, 2018 - Springer
Natural killer/T-cell lymphoma (NKTCL) is a rare subtype of non-Hodgkin lymphoma that is
associated with a poor outcome. Currently, the treatment needs of NKTCL remain unmet …
associated with a poor outcome. Currently, the treatment needs of NKTCL remain unmet …
EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment
A Nicolae, S Pittaluga, S Abdullah… - Blood, The Journal …, 2015 - ashpublications.org
Few studies have reported Epstein-Barr virus–positive (EBV+) large B-cell lymphomas
(LBCLs) in young patients without immunodeficiency. We identified 46 such cases in …
(LBCLs) in young patients without immunodeficiency. We identified 46 such cases in …
[HTML][HTML] Molecular profiling of EBV associated diffuse large B-cell lymphoma
F Frontzek, AM Staiger, R Wullenkord, M Grau… - Leukemia, 2023 - nature.com
Epstein-Barr virus (EBV) associated diffuse large B-cell lymphoma (DLBCL) represents a
rare aggressive B-cell lymphoma subtype characterized by an adverse clinical outcome …
rare aggressive B-cell lymphoma subtype characterized by an adverse clinical outcome …
[PDF][PDF] EBV‐positive diffuse large B‐cell lymphoma, not otherwise specified: 2022 update on diagnosis, risk‐stratification, and management
L Malpica, ML Marques‐Piubelli… - American journal of …, 2022 - researchgate.net
Abstract Disease Overview: Epstein Barr virus-positive (EBV+) diffuse large B-cell lymphoma
(DLBCL), not otherwise specified (NOS) is an entity included in the WHO classification of …
(DLBCL), not otherwise specified (NOS) is an entity included in the WHO classification of …
[HTML][HTML] Epstein− Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas
Cancer cells subvert host immune surveillance by altering immune checkpoint (IC) proteins.
Some Epstein− Barr virus (EBV)-associated tumors have higher Programmed Cell Death …
Some Epstein− Barr virus (EBV)-associated tumors have higher Programmed Cell Death …
EBV-positive diffuse large B-cell lymphoma of the elderly
Epstein-Barr virus (EBV) positive diffuse large B-cell lymphoma (DLBCL) of the elderly,
initially described in 2003, is a provisional entity in the 2008 World Health Organization …
initially described in 2003, is a provisional entity in the 2008 World Health Organization …
Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma
Nasopharyngeal carcinoma (NPC) is an epithelial malignancy with a unique geographical
distribution. The genomic abnormalities leading to NPC pathogenesis remain unclear. In …
distribution. The genomic abnormalities leading to NPC pathogenesis remain unclear. In …
[HTML][HTML] Epstein–Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8–9 …
JI Cohen, H Kimura, S Nakamura, YH Ko, ES Jaffe - Annals of Oncology, 2009 - Elsevier
Abstract Background Recently novel Epstein–Barr virus (EBV) lymphoproliferative diseases
(LPDs) have been identified in non-immunocompromised hosts, both in Asia and Western …
(LPDs) have been identified in non-immunocompromised hosts, both in Asia and Western …